Terray

Drug Discovery

This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.

AI-enabled drug design

This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.

Variartional

This company develops generative artificial intelligence to accelerate the discovery and optimization of novel small molecules for biopharmaceutical researchers and drug developers.

Cime Therapeutics

The company develops an automated drug discovery platform using synthetic chemistry and artificial intelligence to create therapeutic molecules for pharmaceutical organisations.

Variational AI

The company develops a generative artificial intelligence platform for small molecule drug discovery for biopharmaceutical and biotechnology organisations.

Tessel Biosciences

The company develops artificial intelligence models and patient-derived virtual tissues to accelerate drug discovery for pharmaceutical and biotechnology organisations.

Ten63 Therapeutics

This company develops small-molecule drugs for pharmaceutical partners and patients using a generative artificial intelligence and physics-based chemistry platform to treat undruggable protein targets.

Duplicat

This company develops artificial intelligence technology to accelerate molecular discovery and enhance drug compound identification for pharmaceutical businesses.